Navigation Links
InspireMD Closes $25 Million Underwritten Public Offering
Date:4/16/2013

TEL AVIV, Israel, April 16, 2013 /PRNewswire/ --

InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR) announced the closing of an underwritten public offering of 12.5 million shares of its common stock at a price to the public of $2.00 per share.  The Company received net proceeds of approximately $22.6 million, after deducting underwriting discounts and commissions and other offering-related costs.  InspireMD granted the underwriters a 30-day option to purchase up to an additional 1.875 million shares to cover over-allotments, if any.

The Company intends to use a portion of the proceeds from the offering to assist in retiring its convertible debentures, to support the worldwide commercialization of the MGuard[TM] Coronary and Carotid Embolic Protection Stents (EPS), to pursue FDA approval in the United States, and for general corporate purposes. Following this offering, the Company will not have any indebtedness for borrowed money outstanding.

Cowen and Company, LLC was sole book runner and JMP Securities acted as co-lead manager.  

The offering of these securities were made only by means of a prospectus. A registration statement relating to these securities has been declared effective by the Securities and Exchange Commission (SEC). The registration statement may be accessed through the SEC's website at http://www.sec.gov.

A prospectus relating to these securities may be obtained from Cowen and Company, LLC (c/o Broadridge Financial Services) at 1155 Long Island Avenue, Edgewood, NY, 11717, Attn: Prospectus Department, or by calling (631) 274-2806.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. InspireMD Announces First Quarter 2012 Financial Results
2. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
3. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
4. InspireMD to Present at Harvard Investors Group on June 27 in New York
5. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
6. InspireMD Reports Results For Period Ending Sept. 30, 2012
7. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
8. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
9. InspireMD Reports Results for Period Ended Dec. 31, 2012
10. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
11. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, ... on discovering, developing and commercializing novel therapeutics from ... closing of the previously announced offering on the ... Depositary Shares (ADSs) at a price of $112.00 ... million (before deducting underwriting discount, commissions and offering ...
(Date:5/5/2015)... 5, 2015 North American ophthalmology ... in 2014, and is estimated to grow to $138.3 ... 2014 to 2019. Browse through the TOC ... an analysis of industry trends and segments, with the ... http://www.micromarketmonitor.com/market/north-america-glaucoma-surgery-devices-8830146604.html Early buyers will receive ...
(Date:5/5/2015)... the Netherlands , May 5, 2015 ... lower esophageal sphincter (LES) stimulation therapy for gastroesophageal ... and efficacy results. The results demonstrated an excellent ... regurgitation and the "gold-standard" esophageal acid exposure (measured ... of dependence on daily PPI medications. ...
Breaking Medicine Technology:GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 2North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019 3Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 2Excellent three year results of EndoStim therapy for severe reflux disease presented at the SAGES Annual Meeting in Nashville. 3
... 3, 2010 , , , ... Artificial Sphincter (the AOS-C1000) to,Provide Bowel Control and Prevent Clinical Complications for People With,Stomas. , ... Stimatix GI, located in the Misgav Venture Accelerator, has reported,encouraging interim results in ... bowel,control. , , , ...
... May 3 Unisys Corporation announced today that it ... (HIM) business to Molina Healthcare, Inc. for $135 million ... , , ... business process outsourcing services to state governments for administering Medicaid and ...
Cached Medicine Technology:Stimatix GI Reports Encouraging Interim Results 2Unisys Completes Sale of Health Information Management Business 2
(Date:5/5/2015)... 2015 Viverae®, a health management ... a leading multinational developer, manufacturer and marketer of ... vascular, urology, oncology and surgical specialty products, as ... The Vanguard Award recognizes outstanding achievement in the ... Viverae’s significant client base. , Viverae reviewed the ...
(Date:5/5/2015)... Sunny skies and cool temperatures made for great ... runners and walkers participated in Global Lyme Alliance’s (GLA) inaugural ... , The 5K and 10K runs and 1-and 3-mile walks ... raise funds for tick-borne disease research. The “Lyme Walk and ... merger of Lyme Research Alliance (LRA) and Tick-Borne Disease ...
(Date:5/5/2015)... Skedans Systems a division of ... Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 ... provides tooling to deliver real time information for decision ... Sensor Collaboration Platform is a single unified cloud software ... Web Real Time Communications (WebRTC), and commercial Unmanned Autonomous ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 This year, ... Medals, four Special Merit Awards, three Gold Medals and ... projects are described as follows: , (1) Grand Prize ... Robotic Mannequin for Fashion Design and Fitting, Principal Investigator: ... , The apparel industry relies very much on the ...
(Date:5/5/2015)... 2015 ProTexting, LLC – a ... deploy Mobile Engagement Campaigns and other Mobile solutions, introduces ... can now leverage the power of Mobile Marketing to ... subscribers’ e-mail addresses into the Constant Contact Platform. , ... the growing trend of multi-channel marketing would become more ...
Breaking Medicine News(10 mins):Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:Skedans Systems Announces Skedans Sensor Collaboration Platform at AUVSI's Unmanned Systems 2015 in Atlanta 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 2Health News:PolyU wins top prizes in Geneva’s Invention Expo 3Health News:PolyU wins top prizes in Geneva’s Invention Expo 4Health News:PolyU wins top prizes in Geneva’s Invention Expo 5Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3
... tumor spread, say it could be target for screening ... report what they say is a major advance toward ... distinguish between aggressive prostate cancers that require urgent treatment ... , Today, many men diagnosed with prostate cancer are ...
... love interfere with your work, researchers say , SUNDAY, Feb. ... your Valentine at work, here,s good news. , Office romances ... a new Canadian study finds. , "Most people believe romantic ... affect productivity, de-motivate other colleagues or have an impact on ...
... ... Joy Behar Show in January of 2010, Michelle Pearl is Now Using Her New ... Loser" and its Bombastic, Outspoken Trainer , ... (PRWEB) February 14, 2010 -- Michelle Pearl, a self-described “physically ...
... ... hospitals, clinics, and private practices. , ... Ferndale, MI (PRWEB) February 14, 2010 -- Today Enovate announced the release of ... be simple, light-weight, and cost effective solution. From emergency and operating rooms to radiology labs ...
... Skin ... , ... -- Elias Medical recently opened the doors to its new practice in Bakersfield’s growing River ... 9900 Stockdale Highway, adjacent to California State University, Bakersfield and Mercy Southwest Hospital. , , ...
... , WASHINGTON , Feb. 14 Following is ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO ) , SUNDAY, FEBRUARY 14 ... for the 14th day of Black History Month.  Dr. Daniel ... the end of the 19th century.  He founded Provident Hospital, the nation,s ...
Cached Medicine News:Health News:Advance Toward Test for Aggressive Prostate Cancer 2Health News:Advance Toward Test for Aggressive Prostate Cancer 3Health News:Office Romance OK With Most Folks 2Health News:AntiBiggestLoser.com; New Blog Takes Aim at Worldwide Reality TV Show, "The Biggest Loser" 2Health News:AntiBiggestLoser.com; New Blog Takes Aim at Worldwide Reality TV Show, "The Biggest Loser" 3Health News:Enovate Announces New Customizable Enovate Lite Medical Cart Series 2Health News:Enovate Announces New Customizable Enovate Lite Medical Cart Series 3Health News:Elias Medical Announces Move to New Stockdale Highway Practice 2Health News:U.S. Census Bureau Black History Month Feature for Feb. 14 2
...
...
Headlight module is mounted on UltraLite Plus headband or sweatband....
It is a magnifying headlight perfect for all applications and procedures where clear magnification and a natural white light increase accuracy and productivity....
Medicine Products: